Protagonist Therapeutics eyes a Johnson & Johnson buyout interest, with blockbuster drug potential and high acquisition hopes ...

Delta Air Lines, Inc. (NYSE: DAL) released its third-quarter financial results before Thursday’s opening bell. Below are the transcripts from the third quarter earnings call. •DAL is among today’s top ...